US-Listed Public Company Profile built from SEC and market records · June 2026

Medpace Holdings, Inc. (MEDP)

$676.77 +1.13% NASDAQ: MEDP · 15-min delayed

CINCINNATI, Ohio
Public · NASDAQ: MEDP
6,500 employees

Visit website Follow

$16.8BMarket cap

$2.5BRevenue · FY2025

$451.1MNet income

6,500Employees

MEDPNASDAQ

2016IPO

About Medpace Holdings, Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Company facts

Type: Public · NASDAQ: MEDP
Employees: 6,500
IPO date: Aug 11, 2016
Headquarters: 5375 MEDPACE WAY
CINCINNATI, Ohio 45227
Phone: (513) 579-9911
Industry: Pharmaceuticals
Website: Visit site

Incorporation record

Incorporated in: DE, United States
Registered office: Wilmington, US
Legal entity ID: 549300H8TYEUVTW14A54

Source: GLEIF, the global Legal Entity Identifier registry · checked Jul 26, 2026. A US headquarters does not always mean US incorporation.

Is Medpace Holdings, Inc. an American company? Yes. Medpace Holdings, Inc. is incorporated in Delaware, United States and headquartered in Cincinnati, Ohio. Its legal-entity record reports no foreign parent — the company is independently American-owned.

Registry IDs

Ticker: MEDP Nasdaq
SEC CIK: 1668397
LEI: 549300H8TYEUVTW14A54
EIN: 320434904
SIC: 8731 SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH

Explore our data studies: the biggest company in every US state · all rankings & reports.

Embed this company’s badge

Show Medpace Holdings, Inc.’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/medpace-holdings-inc/"><img src="https://americancompanies.com/badge/medpace-holdings-inc.svg" alt="Medpace Holdings, Inc. — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it free, control the page, and activate the embeddable Verified badge for their own website.

Claim this profile — free

Track American companies

Create a free account to follow Medpace Holdings, Inc. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Revenue FY2025: $2.5B
Net income: $451.1M
Total assets: $2.0B
Market cap: $16.8B

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: MEDP

$676.77 +1.13%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$393.42 $676.77

52-week range

Market cap: $16.8B
Shares outstanding: 24.8M
Open: —
Day range: –
Prev close: —
Volume: —
IPO date: Aug 11, 2016

Medpace Holdings, Inc. (MEDP) Stock Price

Profitable — net income of $451.1M in FY2025.
Trading near its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

Peers & competitors

Hims & Hers Health, Inc.HIMS

Elevance Health, Inc.ELV

Encompass Health CorpEHC

IQVIA HOLDINGS INC.IQV

No reviews yet. Be the first to review Medpace Holdings, Inc..

Write a review

Newsroom

News about Medpace Holdings, Inc.

AC Original Medpace Holdings: A Cincinnati Research Firm's Quiet Financial Surge A plain-English look at Medpace's revenue, profit, and market value as the Cincinnati clinical-trial company grows into… Jul 24, 2026

Is Medpace (MEDP) a Solid Growth Stock? 3 Reasons to Think "Yes" Zacks Investment Research · 2026-10-26 · positive All You Need to Know About Medpace (MEDP) Rating Upgrade to Buy Zacks Investment Research · 2026-10-26 · positive Medpace: 3 Key Takeaways for Long-Term Investors The Motley Fool · 2026-10-23 · positive Medpace (MEDP) Q3 Earnings and Revenues Beat Estimates Zacks Investment Research · 2026-10-21 · neutral CON vs. MEDP: Which Stock Should Value Investors Buy Now? Zacks Investment Research · 2026-10-14 · negative Medpace (MEDP) Dips More Than Broader Market: What You Should Know Zacks Investment Research · 2026-10-13 · neutral

News & sentiment via Polygon.io

FAQ

Medpace Holdings, Inc.: frequently asked questions

Is Medpace Holdings, Inc. an American company?

Yes — Medpace Holdings, Inc. is an American company. Medpace Holdings, Inc. is incorporated in Delaware, United States and headquartered in Cincinnati, Ohio. Its legal-entity record reports no foreign parent — the company is independently American-owned.

Where is Medpace Holdings, Inc. incorporated?

Medpace Holdings, Inc. is legally incorporated in Delaware, United States, according to its GLEIF legal-entity record.

Who owns Medpace Holdings, Inc.?

Medpace Holdings, Inc. reports no parent company in its legal-entity record — it is independently owned rather than a subsidiary.

Is Medpace Holdings, Inc. traded on a US stock exchange?

Yes — Medpace Holdings, Inc. trades under the ticker MEDP on the NASDAQ.

Where is Medpace Holdings, Inc. headquartered?

Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio, United States.

Is Medpace Holdings, Inc. publicly traded?

Yes — Medpace Holdings, Inc. is a publicly traded company. Its stock trades under the ticker symbol MEDP on the NASDAQ.

What does Medpace Holdings, Inc. do?

Medpace Holdings, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.